Overall, because it is difficult to predict whether these immune dysfunctions induced by B cell NF-κB blockade occur in EAE or MS and affect their pathophysiology, further investigations are needed to explore this unidentified issue. The gene discussed is NFKB1; the disease is myeloid sarcoma.